CN104005179A - Method for preparing polycaprolactone-keratin composite nanometer fiber pipe - Google Patents
Method for preparing polycaprolactone-keratin composite nanometer fiber pipe Download PDFInfo
- Publication number
- CN104005179A CN104005179A CN201410263648.8A CN201410263648A CN104005179A CN 104005179 A CN104005179 A CN 104005179A CN 201410263648 A CN201410263648 A CN 201410263648A CN 104005179 A CN104005179 A CN 104005179A
- Authority
- CN
- China
- Prior art keywords
- polycaprolactone
- keratin
- solution
- preparation
- fiber pipe
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Materials For Medical Uses (AREA)
Abstract
本发明涉及一种聚己内酯-角蛋白复合纳米纤维管的制备方法,包括:将聚己内酯溶于溶剂中,搅拌溶解,得到聚己内酯溶液;将角蛋白溶于溶剂中,搅拌溶解,得到角蛋白溶液;将聚己内酯溶液和角蛋白溶液按质量比为95:5-5:95混合,搅拌混匀,得到纺丝液,然后进行静电纺丝,并以圆柱形的收集辊为接收器,得到聚己内酯-角蛋白复合纳米纤维管。本发明得到的管状材料即保持了角蛋白良好的生物活性,又具备聚己内酯良好的韧性和力学强度,同时具有内径尺寸可调、制备方法简单等优点,有望用于人工血管等领域。The invention relates to a preparation method of a polycaprolactone-keratin composite nanofiber tube, comprising: dissolving polycaprolactone in a solvent, stirring and dissolving to obtain a polycaprolactone solution; dissolving keratin in a solvent, Stir and dissolve to obtain a keratin solution; mix the polycaprolactone solution and the keratin solution at a mass ratio of 95:5-5:95, stir and mix to obtain a spinning solution, and then carry out electrospinning and spin in a cylindrical shape The collection roller was used as a receiver to obtain polycaprolactone-keratin composite nanofiber tubes. The tubular material obtained by the invention not only maintains good biological activity of keratin, but also has good toughness and mechanical strength of polycaprolactone, and has the advantages of adjustable inner diameter and simple preparation method, and is expected to be used in artificial blood vessels and other fields.
Description
技术领域technical field
本发明属于纳米纤维管的制备领域,特别涉及一种聚己内酯-角蛋白复合纳米纤维管的制备方法。The invention belongs to the field of preparation of nanofiber tubes, in particular to a preparation method of polycaprolactone-keratin composite nanofiber tubes.
背景技术Background technique
角蛋白是一种不溶性的纤维状动物蛋白质,是外胚层细胞的结构蛋白,广泛存在于动物皮肤及皮肤附属物中,如毛发、蹄、壳、爪、角、鳞片等。近几年的大量研究表明,角蛋白是一种生物相容性好且不被机体免疫排斥的优质生物医用材料,具有广阔的应用前景。最为突出的是,经过对羊毛等来源的角蛋白进行氨基酸序列测定发现,其含有同Arg-Gly-Asp(RGD)三肽序列。此三肽序列被公认为是细胞外基质中实现细胞结合的有效结合位点,有促进细胞吸附的功能。因此,国内外已开展大量关于角蛋白基生物材料的基础研究及动物实验研究,并在创伤敷料[Wound Repair and Regeneration,2012,20:236-242]、人造骨[Journal of Bioactive and Compatible Polymers,2013,28:141-153]以及神经修复[Biomaterials34(2013)5907-5914]等方面都取得了良好效果,已有部分产品应用于临床。Keratin is an insoluble fibrous animal protein, a structural protein of ectodermal cells, widely present in animal skin and skin appendages, such as hair, hooves, shells, claws, horns, scales, etc. A large number of studies in recent years have shown that keratin is a high-quality biomedical material with good biocompatibility and not rejected by the body's immune system, and has broad application prospects. Most prominently, the amino acid sequence of keratin derived from wool and other sources was found to contain the same Arg-Gly-Asp (RGD) tripeptide sequence. This tripeptide sequence is recognized as an effective binding site for cell binding in the extracellular matrix, and has the function of promoting cell adsorption. Therefore, a large number of basic research and animal experiment research on keratin-based biomaterials have been carried out at home and abroad, and have been widely used in wound dressings [Wound Repair and Regeneration, 2012, 20: 236-242], artificial bone [Journal of Bioactive and Compatible Polymers, 2013,28:141-153] and nerve repair [Biomaterials34 (2013) 5907-5914] have achieved good results, and some products have been used clinically.
但现有研究证明,由于角蛋白的分子量较低,单一的角蛋白材料制成的膜材料通常较脆,且力学强度不高,使其应用性受到限制。因此,目前,大多数的角蛋白基生物材料往往采用角蛋白与天然高分子或人工高分子复合,这样既可以保持以改善单一角蛋白力学性能较差的不足,如丝素蛋白[Biomacromolecules,2008,9,1299–1305]、PVA[Advances inMaterials Science and Engineering,2014,Article ID163678]、PLGA[Journal of Bioactive andCompatible Polymers,2013,28:141-153]、PLLA[Biomed.Mater.2013,8:1-9]等。聚己内酯(PCL)是一种商业化的医用高分子材料,具有良好的生物相容性和可降解性,已通过美国药监局的批准,被广泛应用于药物载体、组织工程材料等生物医用领域。然而,聚己内酯材料本身无生物活性,缺少细胞识别信号位点,不利于内皮细胞等组织细胞的粘附和生长。However, existing studies have shown that due to the low molecular weight of keratin, the membrane material made of a single keratin material is usually brittle and has low mechanical strength, which limits its application. Therefore, at present, most keratin-based biomaterials often use keratin and natural polymers or artificial polymers, which can maintain and improve the poor mechanical properties of single keratin, such as silk fibroin [Biomacromolecules, 2008 ,9,1299–1305], PVA[Advances in Materials Science and Engineering,2014,Article ID163678], PLGA[Journal of Bioactive and Compatible Polymers,2013,28:141-153], PLLA[Biomed.Mater.2013,8:1 -9] etc. Polycaprolactone (PCL) is a commercial medical polymer material with good biocompatibility and degradability. It has been approved by the US Food and Drug Administration and is widely used in drug carriers, tissue engineering materials, etc. biomedical field. However, the polycaprolactone material itself has no biological activity and lacks cell recognition signal sites, which is not conducive to the adhesion and growth of tissue cells such as endothelial cells.
据此,本发明提出将角蛋白与聚己内酯复合,并采用静电纺丝的方法制备纳米纤维型管状材料,以期改善单一角蛋白纤维材料力学性能较低的不足。静电纺丝技术是指利用高压电场环境使聚合物纺丝液形成带电的喷射流,该喷射流在电场作用下被拉长,溶剂挥发,最后在接收装置上形成一定形态的纳米纤维。近十几年来,该技术已成为制备纳米纤维材料的有效途径之一,所得纳米纤维孔隙率高,形态可控,被广泛应用于膜状及管状等组织工程材料领域。Accordingly, the present invention proposes to compound keratin and polycaprolactone, and prepare nanofibrous tubular materials by electrospinning, in order to improve the low mechanical properties of single keratin fiber materials. Electrospinning technology refers to the use of a high-voltage electric field environment to form a charged jet flow from the polymer spinning solution. The jet flow is elongated under the action of the electric field, the solvent is volatilized, and finally nanofibers of a certain shape are formed on the receiving device. In the past ten years, this technology has become one of the effective ways to prepare nanofiber materials. The obtained nanofibers have high porosity and controllable shape, and are widely used in the field of membrane and tubular tissue engineering materials.
发明内容Contents of the invention
本发明所要解决的技术问题是提供一种聚己内酯-角蛋白复合纳米纤维管的制备方法,该发明得到的管状材料即保持了角蛋白良好的生物活性,又具备聚己内酯良好的韧性和力学强度,同时具有内径尺寸可调、制备方法简单等优点,有望用于人工血管等领域。The technical problem to be solved by the present invention is to provide a preparation method of polycaprolactone-keratin composite nanofiber tube. Toughness and mechanical strength, as well as the advantages of adjustable inner diameter and simple preparation method, are expected to be used in artificial blood vessels and other fields.
本发明的一种聚己内酯-角蛋白复合纳米纤维管的制备方法,包括:A kind of preparation method of polycaprolactone-keratin composite nanofiber tube of the present invention comprises:
(1)将聚己内酯溶于溶剂中,搅拌溶解,得到聚己内酯溶液;(1) dissolving polycaprolactone in a solvent, stirring and dissolving to obtain a polycaprolactone solution;
(2)将角蛋白溶于溶剂中,搅拌溶解,得到角蛋白溶液;(2) dissolving keratin in a solvent, stirring and dissolving to obtain a keratin solution;
(3)将聚己内酯溶液和角蛋白溶液按质量比为95:5-5:95混合,搅拌混匀,得到纺丝液(聚己内酯/角蛋白混合溶液),然后进行静电纺丝,并以圆柱形的收集辊为接收器,得到聚己内酯-角蛋白复合纳米纤维管。(3) Mix polycaprolactone solution and keratin solution at a mass ratio of 95:5-5:95, stir and mix to obtain spinning solution (polycaprolactone/keratin mixed solution), and then perform electrospinning Filament, and the cylindrical collection roller as a receiver, to obtain polycaprolactone-keratin composite nanofiber tubes.
所述步骤(1)中溶剂为六氟异丙醇、甲酸、乙酸、N,N-二甲基甲酰胺、N,N-二甲基乙酰胺、N-甲基吡咯烷酮、二氯甲烷、二氯乙烷、氯仿、二甲基亚砜、四氢呋喃中的一种或几种。优选六氟异丙醇。In the described step (1), the solvent is hexafluoroisopropanol, formic acid, acetic acid, N, N-dimethylformamide, N, N-dimethylacetamide, N-methylpyrrolidone, dichloromethane, di One or more of ethyl chloride, chloroform, dimethyl sulfoxide, and tetrahydrofuran. Hexafluoroisopropanol is preferred.
所述步骤(1)中聚己内酯溶液浓度为5-20mg/ml。The concentration of the polycaprolactone solution in the step (1) is 5-20 mg/ml.
所述步骤(2)中角蛋白的分子量为3-300kDa。The molecular weight of keratin in the step (2) is 3-300kDa.
所述的角蛋白可以是采用目前已公开报道的各种方法提取制备的角蛋白,包括还原法,氧化法以及水解法等,也可以是上述角蛋白的衍生物,如羧甲基角蛋白。The keratin can be keratin extracted and prepared by various methods reported so far, including reduction method, oxidation method and hydrolysis method, etc., and can also be a derivative of the above-mentioned keratin, such as carboxymethyl keratin.
所述的角蛋白可以从人发、羊毛、家禽羽毛、牛毛等人或动物毛发提取而得,也可以是来源于其他已报道的动物体。The keratin can be extracted from human or animal hairs such as human hair, wool, poultry feathers, cow hair, or other reported animal bodies.
所述步骤(2)中溶剂为六氟异丙醇、甲酸、乙酸、N,N-二甲基甲酰胺、N,N-二甲基乙酰胺、N-甲基吡咯烷酮、二氯甲烷、二氯乙烷、氯仿、二甲基亚砜、四氢呋喃中的一种或几种。优选六氟异丙醇。In the step (2), the solvent is hexafluoroisopropanol, formic acid, acetic acid, N,N-dimethylformamide, N,N-dimethylacetamide, N-methylpyrrolidone, dichloromethane, di One or more of ethyl chloride, chloroform, dimethyl sulfoxide, and tetrahydrofuran. Hexafluoroisopropanol is preferred.
所述步骤(2)中角蛋白溶液浓度为10-20mg/ml。The concentration of the keratin solution in the step (2) is 10-20 mg/ml.
所述步骤(3)中纺丝液的质量百分浓度为5-20%。The mass percent concentration of the spinning solution in the step (3) is 5-20%.
所述步骤(3)中的聚己内酯/角蛋白混合溶液,可以加入有利于提高和改善其应用性能的其它物质,包括药物、无机或有机类抗菌剂、肝素等抗凝血剂等。The polycaprolactone/keratin mixed solution in the step (3) can be added with other substances that are conducive to improving and improving its application performance, including drugs, inorganic or organic antibacterial agents, anticoagulants such as heparin, and the like.
所述步骤(3)中静电纺丝工艺参数为电压13-35kV,接收距离8-22cm,纺丝速率为0.3-1.5ml/h,收集辊转动速率60-130rpm,喷丝孔内径为0.7-0.9mm,纺丝温度20-30℃,纺丝湿度45-65%。The electrospinning process parameters in the step (3) are a voltage of 13-35kV, a receiving distance of 8-22cm, a spinning rate of 0.3-1.5ml/h, a collection roller rotation rate of 60-130rpm, and an inner diameter of a spinneret hole of 0.7- 0.9mm, spinning temperature 20-30℃, spinning humidity 45-65%.
所述步骤(3)中圆柱形的收集辊直径尺寸可以是0.6-2厘米,或依据所需管状材料的内径尺寸需求进行调节;收集辊的轴垂直于纺丝喷嘴开口方向,并做匀速转动,转速为60-130rpm。The diameter of the cylindrical collection roller in the step (3) can be 0.6-2 cm, or be adjusted according to the inner diameter of the required tubular material; the axis of the collection roller is perpendicular to the opening direction of the spinning nozzle and rotates at a constant speed , the speed is 60-130rpm.
有益效果Beneficial effect
本发明得到的管状材料即保持了角蛋白良好的生物活性,又具备聚己内酯良好的韧性和力学强度,同时具有内径尺寸可调、生物相容性好、可降解,制备方法简单等优点,有望用于人工血管等领域。The tubular material obtained by the invention not only maintains good biological activity of keratin, but also has good toughness and mechanical strength of polycaprolactone, and has the advantages of adjustable inner diameter, good biocompatibility, degradability, and simple preparation method. , is expected to be used in artificial blood vessels and other fields.
具体实施方式Detailed ways
下面结合具体实施例,进一步阐述本发明。应理解,这些实施例仅用于说明本发明而不用于限制本发明的范围。此外应理解,在阅读了本发明讲授的内容之后,本领域技术人员可以对本发明作各种改动或修改,这些等价形式同样落于本申请所附权利要求书所限定的范围。Below in conjunction with specific embodiment, further illustrate the present invention. It should be understood that these examples are only used to illustrate the present invention and are not intended to limit the scope of the present invention. In addition, it should be understood that after reading the teachings of the present invention, those skilled in the art can make various changes or modifications to the present invention, and these equivalent forms also fall within the scope defined by the appended claims of the present application.
实施例1Example 1
以羊毛为原料采用还原法提取角蛋白,具体方法为:称取5g羊毛,以石油醚为溶剂采用索氏抽提法去除羊毛表面油脂,然后用乙醇清洗羊毛,风干。将上述羊毛加入100ml、1mol/l的巯基乙醇中,用NaOH调节pH约10.0,然后在40℃条件反应12h。反应结束后,将反应液收集(记为滤液1),同时将反应剩余的羊毛固体过滤收集,继续用100ml、0.1mol/l的Tris碱液在40℃条件下处理2h,然后过滤除去固体,收集滤液(记为滤液2)。.将滤液1和2合并,于6000rpm离心5分钟,然后用截留分子量40,000的透析袋透析36h,最后将透析液加入液氮进行速冻处理,然后置入冷冻干燥机干燥得到干态的角蛋白粉末。The keratin was extracted from wool by reduction method. The specific method was: weigh 5g of wool, use petroleum ether as solvent to remove the oil on the surface of wool by Soxhlet extraction, then wash the wool with ethanol and air-dry it. Add the above-mentioned wool into 100ml, 1mol/l mercaptoethanol, adjust the pH to about 10.0 with NaOH, and then react at 40°C for 12h. After the reaction was finished, the reaction solution was collected (referred to as filtrate 1), and the wool solid remaining in the reaction was collected by filtration, and continued to be treated with 100ml, 0.1mol/l Tris lye at 40°C for 2h, and then filtered to remove the solid. The filtrate was collected (designated as filtrate 2). .The filtrates 1 and 2 were combined, centrifuged at 6000rpm for 5 minutes, and then dialyzed with a dialysis bag with a molecular weight cut-off of 40,000 for 36 hours. Finally, the dialysate was added to liquid nitrogen for quick freezing, and then dried in a freeze dryer to obtain dry keratin powder .
聚己内酯-角蛋白复合纳米纤维膜的制备:将质量为0.15g的聚己内酯溶于10ml六氟异丙醇,室温下进行磁力搅拌至完全溶解,得到浓度为15mg/ml的聚己内酯溶液。将0.2g角蛋白固体溶于10ml六氟异丙醇,室温下进行磁力搅拌至完全溶解,得到浓度为20mg/ml的角蛋白溶液。将上述聚己内酯与角蛋白溶液按照质量比50:50的比例进行混合,纺丝液的总浓度为15%,磁力搅拌至混合均匀。将上述所得聚己内酯/角蛋白溶液进行静电纺丝,静电纺丝参数为电压15kV,接收距离12cm,纺丝速率为0.5ml/h,喷丝孔内径为0.7mm,纺丝温度25℃,纺丝湿度50%。以直径1.0cm的圆柱形收集辊为接收器接收喷射产生的纳米丝,收集辊的转动速率为100rpm,经过4小时的收集,得到聚己内酯-角蛋白复合纳米纤维管状材料。Preparation of polycaprolactone-keratin composite nanofiber membrane: dissolve polycaprolactone with a mass of 0.15 g in 10 ml hexafluoroisopropanol, and stir magnetically at room temperature until completely dissolved to obtain a polycaprolactone with a concentration of 15 mg/ml. caprolactone solution. 0.2 g of solid keratin was dissolved in 10 ml of hexafluoroisopropanol, and magnetically stirred at room temperature until completely dissolved to obtain a keratin solution with a concentration of 20 mg/ml. The above polycaprolactone and keratin solution were mixed according to the mass ratio of 50:50, the total concentration of the spinning solution was 15%, and magnetically stirred until uniformly mixed. The polycaprolactone/keratin solution obtained above was subjected to electrospinning, the electrospinning parameters were voltage 15kV, receiving distance 12cm, spinning rate 0.5ml/h, spinneret inner diameter 0.7mm, spinning temperature 25°C , Spinning humidity 50%. A cylindrical collection roller with a diameter of 1.0 cm was used as a receiver to receive the nanofilaments generated by the jet. The rotation speed of the collection roller was 100 rpm. After 4 hours of collection, the polycaprolactone-keratin composite nanofiber tubular material was obtained.
实施例2Example 2
以人发为原料采用还原法提取角蛋白,具体方法为:称取5g人发,以石油醚为溶剂采用索氏抽提法去除人发表面油脂,然后用乙醇清洗人发,风干。将上述人发加入200ml水与5g焦亚硫酸钠混合的溶液中,用NaOH调节pH约10.0,然后在60℃条件反应5h。反应结束后,将反应液收集(记为滤液1),同时将反应剩余的人发固体过滤收集,继续用100ml、0.1mol/l的Tris碱液在40℃条件下处理2h,然后过滤除去固体,收集滤液(记为滤液2)。.将滤液1和2合并,于6000rpm离心5分钟,然后用截留分子量8,000的透析袋透析36h,最后将透析液加入液氮进行速冻处理,然后置入冷冻干燥机干燥得到干态的角蛋白粉末。Using human hair as raw material to extract keratin by reduction method, the specific method is: weigh 5g of human hair, use petroleum ether as solvent to remove human hair surface oil by Soxhlet extraction, then wash human hair with ethanol and air-dry. Add the above-mentioned human hair into a mixed solution of 200ml of water and 5g of sodium metabisulfite, adjust the pH to about 10.0 with NaOH, and then react at 60°C for 5h. After the reaction, collect the reaction solution (referred to as filtrate 1), and collect the remaining human hair solid by filtration at the same time, continue to treat it with 100ml, 0.1mol/l Tris lye at 40°C for 2h, and then filter to remove the solid , collect the filtrate (referred to as filtrate 2). .The filtrates 1 and 2 were combined, centrifuged at 6000rpm for 5 minutes, and then dialyzed with a dialysis bag with a molecular weight cut-off of 8,000 for 36 hours. Finally, the dialysate was added to liquid nitrogen for quick freezing, and then dried in a freeze dryer to obtain dry keratin powder .
聚己内酯-角蛋白复合纳米纤维膜的制备:将质量为0.2g的聚己内酯溶于10ml甲酸中,室温下进行磁力搅拌至完全溶解,得到浓度为20mg/ml的聚己内酯溶液。将0.15g角蛋白固体溶于甲酸中,室温下进行磁力搅拌至完全溶解,得到浓度为15mg/ml的角蛋白溶液。将上述聚己内酯与角蛋白溶液按照质量比20:80的比例进行混合,纺丝液的总浓度为10%,磁力搅拌至混合均匀。将上述所得聚己内酯/角蛋白溶液进行静电纺丝,静电纺丝参数为电压13kV,接收距离10cm,纺丝速率为0.8ml/h,喷丝孔内径为0.7mm,纺丝温度30℃,纺丝湿度65%。以直径0.6cm的圆柱形收集辊为接收器接收喷射产生的纳米丝,收集辊的转动速率为60rpm,经过4小时的收集,得到聚己内酯-角蛋白复合纳米纤维管状材料。Preparation of polycaprolactone-keratin composite nanofiber membrane: Dissolve polycaprolactone with a mass of 0.2 g in 10 ml formic acid, stir magnetically at room temperature until completely dissolved, and obtain polycaprolactone with a concentration of 20 mg/ml solution. 0.15 g of solid keratin was dissolved in formic acid, and magnetically stirred at room temperature until completely dissolved to obtain a keratin solution with a concentration of 15 mg/ml. The above polycaprolactone and keratin solution were mixed according to the mass ratio of 20:80, the total concentration of the spinning solution was 10%, and magnetically stirred until uniformly mixed. The polycaprolactone/keratin solution obtained above was subjected to electrospinning, the electrospinning parameters were voltage 13kV, receiving distance 10cm, spinning rate 0.8ml/h, spinneret inner diameter 0.7mm, spinning temperature 30°C , Spinning humidity 65%. A cylindrical collection roller with a diameter of 0.6 cm was used as a receiver to receive the nanofilaments produced by the jet. The rotation speed of the collection roller was 60 rpm. After 4 hours of collection, the polycaprolactone-keratin composite nanofiber tubular material was obtained.
实施例3Example 3
以羊毛为原料采用氧化法提取角蛋白,具体方法为:称取5g羊毛,以石油醚为溶剂采用索氏抽提法去除羊毛表面油脂,然后用乙醇清洗羊毛,风干。向上述羊毛中加入100ml去离子水和5ml、30%的双氧水,然后在100℃条件反应2h。反应结束后,将反应液收集(记为滤液1),同时将反应剩余的羊毛固体过滤收集,继续用100ml、0.1mol/l的Tris碱液在40℃条件下处理2h,然后过滤除去固体,收集滤液(记为滤液2)。.将滤液1和2合并,于6000rpm离心5分钟,然后用截留分子量8,000的透析袋透析36h,最后将透析液加入液氮进行速冻处理,然后置入冷冻干燥机干燥得到干态的角蛋白粉末。The keratin is extracted from wool by oxidation method. The specific method is: weigh 5g of wool, use petroleum ether as solvent to remove the oil on the surface of wool by Soxhlet extraction, then wash the wool with ethanol and air-dry it. 100ml of deionized water and 5ml of 30% hydrogen peroxide were added to the wool, and then reacted at 100°C for 2h. After the reaction was finished, the reaction solution was collected (referred to as filtrate 1), and the wool solid remaining in the reaction was collected by filtration, and continued to be treated with 100ml, 0.1mol/l Tris lye at 40°C for 2h, and then filtered to remove the solid. The filtrate was collected (designated as filtrate 2). .The filtrates 1 and 2 were combined, centrifuged at 6000rpm for 5 minutes, and then dialyzed with a dialysis bag with a molecular weight cut-off of 8,000 for 36 hours. Finally, the dialysate was added to liquid nitrogen for quick freezing, and then dried in a freeze dryer to obtain dry horn protein powder.
聚己内酯-角蛋白复合纳米纤维膜的制备:将质量为0.05g的聚己内酯溶于10ml六氟异丙醇中,室温下进行磁力搅拌至完全溶解,得到浓度为5mg/ml的聚己内酯溶液。将0.1g角蛋白固体溶于10ml六氟异丙醇中,室温下进行磁力搅拌至完全溶解,得到浓度为10mg/ml的角蛋白溶液。将上述聚己内酯与角蛋白溶液按照质量比95:5的比例进行混合,纺丝液的总浓度为5%,磁力搅拌至混合均匀。将上述所得聚己内酯/角蛋白溶液进行静电纺丝,静电纺丝参数为电压13kV,接收距离8cm,纺丝速率为1.5ml/h,喷丝孔内径为0.9mm,纺丝温度20℃,纺丝湿度45%。以直径1.5cm的圆柱形收集辊为接收器接收喷射产生的纳米丝,收集辊的转动速率为110rpm,经过3小时的收集,得到聚己内酯-角蛋白复合纳米纤维管状材料。Preparation of polycaprolactone-keratin composite nanofiber membrane: Dissolve polycaprolactone with a mass of 0.05 g in 10 ml hexafluoroisopropanol, stir magnetically at room temperature until completely dissolved, and obtain a polycaprolactone with a concentration of 5 mg/ml Polycaprolactone solution. 0.1 g of solid keratin was dissolved in 10 ml of hexafluoroisopropanol, and magnetically stirred at room temperature until completely dissolved to obtain a keratin solution with a concentration of 10 mg/ml. The above polycaprolactone and keratin solution were mixed according to the mass ratio of 95:5, the total concentration of the spinning solution was 5%, and magnetically stirred until uniformly mixed. The polycaprolactone/keratin solution obtained above was subjected to electrospinning, the electrospinning parameters were voltage 13kV, receiving distance 8cm, spinning rate 1.5ml/h, spinneret inner diameter 0.9mm, spinning temperature 20°C , Spinning humidity 45%. A cylindrical collection roller with a diameter of 1.5 cm was used as a receiver to receive the nanofilaments generated by the jet. The rotation speed of the collection roller was 110 rpm. After 3 hours of collection, the polycaprolactone-keratin composite nanofiber tubular material was obtained.
实施例4Example 4
以羊毛为原料采用氧化法提取角蛋白,具体方法为:称取5g羊毛,以石油醚为溶剂采用索氏抽提法去除羊毛表面油脂,然后用乙醇清洗羊毛,风干。向上述羊毛中加入100ml、4%的过氧乙酸,然后在60℃条件反应5h。反应结束后,将反应液收集(记为滤液1),同时将反应剩余的羊毛固体过滤收集,继续用100ml、0.1mol/l的Tris碱液在40℃条件下处理2h,然后过滤除去固体,收集滤液(记为滤液2)。.将滤液1和2合并,于6000rpm离心5分钟,然后用截留分子量8,000的透析袋透析36h,最后将透析液加入液氮进行速冻处理,然后置入冷冻干燥机干燥得到干态的角蛋白粉末。The keratin is extracted from wool by oxidation method. The specific method is: weigh 5g of wool, use petroleum ether as solvent to remove the oil on the surface of wool by Soxhlet extraction, then wash the wool with ethanol and air-dry it. Add 100 ml of 4% peroxyacetic acid to the above wool, and then react at 60° C. for 5 h. After the reaction was finished, the reaction solution was collected (referred to as filtrate 1), and the wool solid remaining in the reaction was collected by filtration, and continued to be treated with 100ml, 0.1mol/l Tris lye at 40°C for 2h, and then filtered to remove the solid. The filtrate was collected (designated as filtrate 2). .The filtrates 1 and 2 were combined, centrifuged at 6000rpm for 5 minutes, and then dialyzed with a dialysis bag with a molecular weight cut-off of 8,000 for 36 hours. Finally, the dialysate was added to liquid nitrogen for quick freezing, and then dried in a freeze dryer to obtain dry keratin powder .
聚己内酯-角蛋白复合纳米纤维膜的制备:将质量为0.15g的聚己内酯溶于10ml甲酸中,室温下进行磁力搅拌至完全溶解,得到浓度为15mg/ml的聚己内酯溶液。将0.2g角蛋白固体溶于10ml甲酸中,室温下进行磁力搅拌至完全溶解,得到浓度为20mg/ml的角蛋白溶液。将上述聚己内酯与角蛋白溶液按照质量比5:95的比例进行混合,纺丝液的总浓度为20%,磁力搅拌至混合均匀。将上述所得聚己内酯/角蛋白溶液进行静电纺丝,静电纺丝参数为电压35kV,接收距离22cm,纺丝速率为1.5ml/h,喷丝孔内径为0.9mm,纺丝温度20℃,纺丝湿度55%。以直径1.0cm的圆柱形收集辊为接收器接收喷射产生的纳米丝,收集辊的转动速率为130rpm,经过3小时的收集,得到聚己内酯-角蛋白复合纳米纤维管状材料。Preparation of polycaprolactone-keratin composite nanofiber membrane: Dissolve polycaprolactone with a mass of 0.15 g in 10 ml formic acid, stir magnetically at room temperature until completely dissolved, and obtain polycaprolactone with a concentration of 15 mg/ml solution. 0.2 g of solid keratin was dissolved in 10 ml of formic acid, and magnetically stirred at room temperature until completely dissolved to obtain a keratin solution with a concentration of 20 mg/ml. The above polycaprolactone and keratin solution were mixed according to the mass ratio of 5:95, the total concentration of the spinning solution was 20%, and magnetically stirred until uniformly mixed. The polycaprolactone/keratin solution obtained above was subjected to electrospinning, the electrospinning parameters were voltage 35kV, receiving distance 22cm, spinning rate 1.5ml/h, spinneret inner diameter 0.9mm, spinning temperature 20°C , Spinning humidity 55%. A cylindrical collection roller with a diameter of 1.0 cm was used as a receiver to receive the nanofilaments generated by the jet. The rotation speed of the collection roller was 130 rpm. After 3 hours of collection, the polycaprolactone-keratin composite nanofiber tubular material was obtained.
实施例5Example 5
将以羊毛为原料采用还原法提取角蛋白,并对角蛋白进行衍生化改性。具体方法为:称取5g羊毛,以石油醚为溶剂采用索氏抽提法去除羊毛表面油脂,然后用乙醇清洗羊毛,风干。将上述羊毛加入100ml、1mol/l的巯基乙醇中,用NaOH调节pH约10.0,然后在40℃条件反应12h。然后,用醋酸将上述反应液pH调整到7.5,向其中加入100ml、0.33mol/l的NaBrO3溶液,在室温条件下继续搅拌24h。反应结束后,过滤除去固体物,将滤液收集并用截留分子量8,000的透析袋透析36h,最后将透析液加入液氮进行速冻处理,然后置入冷冻干燥机干燥得到干态的羧甲基角蛋白粉末。The wool is used as raw material to extract keratin by reduction method, and the keratin is derivatized and modified. The specific method is as follows: take 5 g of wool, use petroleum ether as a solvent to remove the oil on the surface of the wool by Soxhlet extraction, then wash the wool with ethanol and air-dry it. Add the above-mentioned wool into 100ml, 1mol/l mercaptoethanol, adjust the pH to about 10.0 with NaOH, and then react at 40°C for 12h. Then, the pH of the above reaction solution was adjusted to 7.5 with acetic acid, 100 ml of 0.33 mol/l NaBrO3 solution was added thereto, and stirring was continued for 24 h at room temperature. After the reaction, remove the solid matter by filtration, collect the filtrate and dialyze it with a dialysis bag with a molecular weight cut-off of 8,000 for 36 hours, and finally add the dialysate to liquid nitrogen for quick freezing, and then dry it in a freeze dryer to obtain dry carboxymethyl keratin powder .
聚己内酯-角蛋白复合纳米纤维膜的制备:将质量为0.15g的聚己内酯溶于10ml六氟异丙醇中,室温下进行磁力搅拌至完全溶解,得到浓度为15mg/ml的聚己内酯溶液。将0.1g羧甲基角蛋白固体溶于10ml六氟异丙醇中,室温下进行磁力搅拌至完全溶解,得到浓度为10mg/ml的羧甲基角蛋白溶液。将上述聚己内酯与角蛋白溶液按照质量比5:95的比例进行混合,磁力搅拌至混合均匀。将上述所得聚己内酯/角蛋白溶液进行静电纺丝,纺丝液的总浓度为15%,静电纺丝参数为电压15kV,接收距离12cm,纺丝速率为1.0ml/h,喷丝孔内径为0.7mm,纺丝温度15℃,纺丝湿度55%。以直径1.0cm的圆柱形收集辊为接收器接收喷射产生的纳米丝,收集辊的转动速率为100rpm,经过4小时的收集,得到聚己内酯-角蛋白复合纳米纤维管状材料。Preparation of polycaprolactone-keratin composite nanofiber membrane: Dissolve polycaprolactone with a mass of 0.15 g in 10 ml hexafluoroisopropanol, and stir magnetically at room temperature until it is completely dissolved to obtain a polycaprolactone with a concentration of 15 mg/ml. Polycaprolactone solution. 0.1 g of solid carboxymethyl keratin was dissolved in 10 ml of hexafluoroisopropanol, and magnetically stirred at room temperature until completely dissolved to obtain a carboxymethyl keratin solution with a concentration of 10 mg/ml. The above polycaprolactone and keratin solution were mixed according to the mass ratio of 5:95, and magnetically stirred until the mixture was uniform. The polycaprolactone/keratin solution obtained above is electrospun, the total concentration of the spinning solution is 15%, the electrospinning parameters are a voltage of 15kV, a receiving distance of 12cm, a spinning rate of 1.0ml/h, and a spinneret hole The inner diameter is 0.7mm, the spinning temperature is 15°C, and the spinning humidity is 55%. A cylindrical collection roller with a diameter of 1.0 cm was used as a receiver to receive the nanofilaments generated by the jet. The rotation speed of the collection roller was 100 rpm. After 4 hours of collection, the polycaprolactone-keratin composite nanofiber tubular material was obtained.
实施例6Example 6
以人发为原料采用还原法提取角蛋白,并对角蛋白进行衍生化改性。具体方法为:称取5g人发,以石油醚为溶剂采用索氏抽提法去除人发表面油脂,然后用乙醇清洗人发,风干。将上述人发加入200ml水与5g焦亚硫酸钠混合的溶液中,用NaOH调节pH约10.0,然后在60℃条件反应5h。然后,用醋酸将上述反应液pH调整到8.5,向其中加入8.0g碘乙酸,在室温条件下继续搅拌6h。反应结束后,过滤除去固体物,将滤液收集并用截留分子量8,000的透析袋透析36h,最后将透析液加入液氮进行速冻处理,然后置入冷冻干燥机干燥得到干态的羧甲基角蛋白粉末。Human hair is used as raw material to extract keratin by reduction method, and the keratin is derivatized and modified. The specific method is as follows: 5g of human hair is weighed, oil on the surface of the human hair is removed by Soxhlet extraction with petroleum ether, then the human hair is washed with ethanol and air-dried. Add the above-mentioned human hair into a mixed solution of 200ml of water and 5g of sodium metabisulfite, adjust the pH to about 10.0 with NaOH, and then react at 60°C for 5h. Then, the pH of the above reaction solution was adjusted to 8.5 with acetic acid, 8.0 g of iodoacetic acid was added thereto, and stirring was continued for 6 h at room temperature. After the reaction, remove the solid matter by filtration, collect the filtrate and dialyze it with a dialysis bag with a molecular weight cut-off of 8,000 for 36 hours, and finally add the dialysate to liquid nitrogen for quick freezing, and then dry it in a freeze dryer to obtain dry carboxymethyl keratin powder .
聚己内酯-角蛋白复合纳米纤维膜的制备:将质量为0.15g的聚己内酯溶于10ml六氟异丙醇,室温下进行磁力搅拌至完全溶解,得到浓度为15mg/ml的聚己内酯溶液。将0.2g羧甲基角蛋白固体溶于10ml六氟异丙醇,室温下进行磁力搅拌至完全溶解,得到浓度为20mg/ml的羧甲基角蛋白溶液。将上述聚己内酯与角蛋白溶液按照质量比50:50的比例进行混合,纺丝液的总浓度为15%,磁力搅拌至混合均匀。将上述所得聚己内酯/角蛋白溶液进行静电纺丝,静电纺丝参数为电压15kV,接收距离12cm,纺丝速率为1.2ml/h,喷丝孔内径为0.7mm,纺丝温度15℃,纺丝湿度55%。以直径1.0cm的圆柱形收集辊为接收器接收喷射产生的纳米丝,收集辊的转动速率为100rpm,经过4小时的收集,得到聚己内酯-角蛋白复合纳米纤维管状材料。Preparation of polycaprolactone-keratin composite nanofiber membrane: dissolve polycaprolactone with a mass of 0.15 g in 10 ml hexafluoroisopropanol, and stir magnetically at room temperature until completely dissolved to obtain a polycaprolactone with a concentration of 15 mg/ml. caprolactone solution. 0.2 g of carboxymethyl keratin solid was dissolved in 10 ml of hexafluoroisopropanol, and magnetically stirred at room temperature until completely dissolved to obtain a carboxymethyl keratin solution with a concentration of 20 mg/ml. The above polycaprolactone and keratin solution were mixed according to the mass ratio of 50:50, the total concentration of the spinning solution was 15%, and magnetically stirred until uniformly mixed. The polycaprolactone/keratin solution obtained above was subjected to electrospinning, the electrospinning parameters were voltage 15kV, receiving distance 12cm, spinning rate 1.2ml/h, spinneret inner diameter 0.7mm, spinning temperature 15°C , Spinning humidity 55%. A cylindrical collection roller with a diameter of 1.0 cm was used as a receiver to receive the nanofilaments generated by the jet. The rotation speed of the collection roller was 100 rpm. After 4 hours of collection, the polycaprolactone-keratin composite nanofiber tubular material was obtained.
实施例7Example 7
按照实施例1中所述的制备方法制备聚己内酯-角蛋白复合纳米纤维管状材料,经分析测定,复合纳米纤维材料在干燥状态下的断裂强度为1.35MPa,断裂伸长率为60%,孔隙率91%。以血管内皮细胞为细胞模型,采用扫描电子显微镜观察细胞在材料上的黏附形态,并通过MTT法对细胞的增殖行为进行评价,结果表明,内皮细胞在复合纳米纤维材料上表现出良好的黏附形态和增殖行为,与单一聚己内酯纳米纤维材料相比具有显著性差异。按照实施例1中所述的制备方法,以单一的角蛋白制备的纳米纤维材料在干燥状态下脆性强、易破碎。Prepare the polycaprolactone-keratin composite nanofiber tubular material according to the preparation method described in Example 1. After analysis, the composite nanofiber material has a breaking strength of 1.35MPa in a dry state and an elongation at break of 60%. , Porosity 91%. Taking vascular endothelial cells as the cell model, the adhesion morphology of cells on the material was observed by scanning electron microscope, and the proliferation behavior of cells was evaluated by MTT method. The results showed that endothelial cells showed good adhesion morphology on the composite nanofiber material. And proliferation behavior, compared with single polycaprolactone nanofibrous material, there are significant differences. According to the preparation method described in Example 1, the nanofibrous material prepared from a single keratin is highly brittle and easily broken in a dry state.
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410263648.8A CN104005179A (en) | 2014-06-13 | 2014-06-13 | Method for preparing polycaprolactone-keratin composite nanometer fiber pipe |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410263648.8A CN104005179A (en) | 2014-06-13 | 2014-06-13 | Method for preparing polycaprolactone-keratin composite nanometer fiber pipe |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104005179A true CN104005179A (en) | 2014-08-27 |
Family
ID=51366074
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410263648.8A Pending CN104005179A (en) | 2014-06-13 | 2014-06-13 | Method for preparing polycaprolactone-keratin composite nanometer fiber pipe |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104005179A (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104784758A (en) * | 2015-05-09 | 2015-07-22 | 南京师范大学 | Preparation method of polymer/keratin composite anticoagulation vascular tissue engineering scaffold |
CN106012297A (en) * | 2016-06-30 | 2016-10-12 | 吉林大学 | Method for preparing medical complex fiber three-dimensional structure dressing |
CN106581777A (en) * | 2017-02-08 | 2017-04-26 | 袁峰 | Polycaprolactone-graphene oxide composite porous scaffold material preparation method |
CN107296979A (en) * | 2017-07-02 | 2017-10-27 | 东华大学 | A kind of organizational project nanofiber intravascular stent and preparation method thereof |
WO2019238610A1 (en) | 2018-06-12 | 2019-12-19 | Kerline S.R.L. | Keratin nanofibers as delivery vehicles of active ingredients, methods for the production and uses thereof |
CN111850818A (en) * | 2019-04-30 | 2020-10-30 | 深圳市罗湖区人民医院 | Preparation method and product of conjugate electrospun nanofiber artificial small-caliber intravascular stent |
CN115467092A (en) * | 2022-09-15 | 2022-12-13 | 大连医科大学附属第二医院 | Preparation method of supported dimethyloxalglycine nanofiber |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004161907A (en) * | 2002-11-13 | 2004-06-10 | Nagoya City | Keratin blended polymer |
US20090202616A1 (en) * | 2004-09-29 | 2009-08-13 | National University Of Singapore | Composite, Method of Producing the Composite and Uses of the Same |
US20100008969A1 (en) * | 2008-07-10 | 2010-01-14 | The Hong Kong Polytechnic University | Biomaterial scaffolds with keratin for tissue engineering |
CN102006837A (en) * | 2008-02-14 | 2011-04-06 | 坦吉恩股份有限公司 | Tissue engineering scaffolds |
US8242073B2 (en) * | 2008-07-10 | 2012-08-14 | The Hong Kong Polytechnic University | Biodegradable and bioabsorbable biomaterials and keratin fibrous articles for medical applications |
CN102917691A (en) * | 2010-06-01 | 2013-02-06 | 巴克斯特国际公司 | Process for making dry and stable hemostatic compositions |
CN102936795A (en) * | 2012-11-28 | 2013-02-20 | 苏州大学 | Drug-loading nano-fiber membrane and preparation method thereof |
CN103147225A (en) * | 2013-02-06 | 2013-06-12 | 东华大学 | Preparation method for protein-polyose-polylactic acid polycaprolactone vascular stent |
CN103205861A (en) * | 2013-03-28 | 2013-07-17 | 苏州正业昌智能科技有限公司 | Electrostatic spun-wool keratin/fibroin composite fiber membrane for absorbing heavy metal ions and preparation method thereof |
CN103394131A (en) * | 2013-07-26 | 2013-11-20 | 宁夏医科大学 | Novel double-layered composite transmitting tissue regeneration membrane and preparation method thereof |
-
2014
- 2014-06-13 CN CN201410263648.8A patent/CN104005179A/en active Pending
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004161907A (en) * | 2002-11-13 | 2004-06-10 | Nagoya City | Keratin blended polymer |
US20090202616A1 (en) * | 2004-09-29 | 2009-08-13 | National University Of Singapore | Composite, Method of Producing the Composite and Uses of the Same |
CN102006837A (en) * | 2008-02-14 | 2011-04-06 | 坦吉恩股份有限公司 | Tissue engineering scaffolds |
US20100008969A1 (en) * | 2008-07-10 | 2010-01-14 | The Hong Kong Polytechnic University | Biomaterial scaffolds with keratin for tissue engineering |
US8242073B2 (en) * | 2008-07-10 | 2012-08-14 | The Hong Kong Polytechnic University | Biodegradable and bioabsorbable biomaterials and keratin fibrous articles for medical applications |
CN102917691A (en) * | 2010-06-01 | 2013-02-06 | 巴克斯特国际公司 | Process for making dry and stable hemostatic compositions |
CN102936795A (en) * | 2012-11-28 | 2013-02-20 | 苏州大学 | Drug-loading nano-fiber membrane and preparation method thereof |
CN103147225A (en) * | 2013-02-06 | 2013-06-12 | 东华大学 | Preparation method for protein-polyose-polylactic acid polycaprolactone vascular stent |
CN103205861A (en) * | 2013-03-28 | 2013-07-17 | 苏州正业昌智能科技有限公司 | Electrostatic spun-wool keratin/fibroin composite fiber membrane for absorbing heavy metal ions and preparation method thereof |
CN103394131A (en) * | 2013-07-26 | 2013-11-20 | 宁夏医科大学 | Novel double-layered composite transmitting tissue regeneration membrane and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
ANGELA EDWARDS.ETC: "Poly(ε-caprolactone)/keratin-based composite nanofibers for biomedical applications", 《SOCIETY FOR BIOMATERIALS》 * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104784758A (en) * | 2015-05-09 | 2015-07-22 | 南京师范大学 | Preparation method of polymer/keratin composite anticoagulation vascular tissue engineering scaffold |
CN104784758B (en) * | 2015-05-09 | 2017-05-10 | 南京师范大学 | Preparation method of polymer/keratin composite anticoagulation vascular tissue engineering scaffold |
CN106012297A (en) * | 2016-06-30 | 2016-10-12 | 吉林大学 | Method for preparing medical complex fiber three-dimensional structure dressing |
CN106581777A (en) * | 2017-02-08 | 2017-04-26 | 袁峰 | Polycaprolactone-graphene oxide composite porous scaffold material preparation method |
CN107296979A (en) * | 2017-07-02 | 2017-10-27 | 东华大学 | A kind of organizational project nanofiber intravascular stent and preparation method thereof |
WO2019238610A1 (en) | 2018-06-12 | 2019-12-19 | Kerline S.R.L. | Keratin nanofibers as delivery vehicles of active ingredients, methods for the production and uses thereof |
CN111850818A (en) * | 2019-04-30 | 2020-10-30 | 深圳市罗湖区人民医院 | Preparation method and product of conjugate electrospun nanofiber artificial small-caliber intravascular stent |
CN111850818B (en) * | 2019-04-30 | 2022-07-15 | 深圳市罗湖区人民医院 | Preparation method and product of conjugate electrospun nanofiber artificial small-caliber intravascular stent |
CN115467092A (en) * | 2022-09-15 | 2022-12-13 | 大连医科大学附属第二医院 | Preparation method of supported dimethyloxalglycine nanofiber |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103993424B (en) | Preparing method of polyurethane-keratin composite nano fiber film | |
CN104018247B (en) | The preparation method of a kind of urethane-Keratin sulfate composite nano fiber tubular material | |
CN104005179A (en) | Method for preparing polycaprolactone-keratin composite nanometer fiber pipe | |
Kerwald et al. | Cellulose-based electrospun nanofibers: A review | |
Han et al. | A review: current status and emerging developments on natural polymer‐based electrospun fibers | |
CN100551449C (en) | Tussah silk fibroin biomedical material and preparation method thereof | |
Zhao et al. | Preparation of nanofibers with renewable polymers and their application in wound dressing | |
CN104004221B (en) | Method for preparing polycaprolactone-keratin composite porous scaffolds | |
Zamani et al. | Recent advances in cell electrospining of natural and synthetic nanofibers for regenerative medicine | |
CN101708344B (en) | Nanofiber vascular prostheses and preparation method | |
CN101703796B (en) | Nano fibre artificial vascular graft modifying internal layer and preparation method thereof | |
CN103993422B (en) | A kind of regenerated silk fibroin/chitosan derivatives blended fiber felt and preparation method thereof | |
CN101502671A (en) | Method for preparing silk fibroin/ P(LLA-CL) compound nano fiber structure repair stand | |
Zhong | Nanofibres for medical textiles | |
CN102277737A (en) | Preparation method and application of polycaprolactone/natural high-molecular composite porous scaffold | |
Zhu et al. | Characterization of a co-electrospun scaffold of HLC/CS/PLA for vascular tissue engineering | |
CN102926027B (en) | Method for preparing modified konjac glucomannan/biodegradation polyester polyblend fibers through electrostatic spinning | |
CN102102278A (en) | Preparation method of silk fibroin-poly(hydroxybutyrate-hydroxyvalerate) composite fiber membrane | |
CN103993425A (en) | Preparing method of polycaprolactone-keratin composite nano fiber film | |
CN105839407B (en) | A kind of surface biological functional method of medical macromolecular materials nanofiber | |
Hosseini Ravandi et al. | Application of electrospun natural biopolymer nanofibers | |
Campiglio et al. | Electrospun ECM macromolecules as biomimetic scaffold for regenerative medicine: Challenges for preserving conformation and bioactivity | |
Syed et al. | Current issues and potential solutions for the electrospinning of major polysaccharides and proteins: A review | |
CN101829366A (en) | Method for preparing small-caliber tubular support electrostatic spinning based on composite nanofiber | |
CN104018245B (en) | A preparation method of silk fibroin/keratin composite nanofiber tubular material |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140827 |